The system that the US FDA is using
to gather and report on information about dangerous side effects from
medications is extremely unreliable and needs a thorough overall, according to
a study reported on by the New York Times. The main problem
is that drug companies are not submitting their data properly.
"The study, by the Institute for
Safe Medication Practices, found that only about half of reports of serious side
effects submitted by manufacturers met basic standards for completeness,
containing a patient’s age, sex and the date the event took place. Reports
collected by the F.D.A. itself, by contrast, were found to meet those basic
standards in 85 percent of cases."
"The difference is noteworthy
because drug makers’ reports account for close to 97 percent of all adverse
events that are collected by the system," continued the Times. "The report
analyzed more than 847,000 case reports received for the 12-month period that
ended in March of 2014. Providing such details can be key to evaluating a drug
and how different groups of people, such as women or older people, might react
to it."
Drug Makers’
Data on Side Effects Is Called Lacking in a Report (New York Times,
February 2, 2015)
Also see:
FDA study spanks
drugmakers for poor adverse events reporting (FiercePharma, February
3, 2015)
FDA System for
Reporting Side Effects Needs a ‘Thorough Overhaul:’ Study
(Pharmalot, Wall Street Journal, February 2, 2015)
--Rob Wipond,
News Editor
This
entry was posted in Adverse Effects, Bias, Corruption & Accountability, Featured News, In the News, Research.
Bookmark the permalink.
RELATED POSTS
Researchers
Faked Data on Epigenetics of Bipolar Disorder September 16,
2014
Thank You Mr Wipond and MIA.
No comments:
Post a Comment
All standard cautions apply. Your milage may vary.
So Try to be an Adult, [no carpet F bombings, Pron, open threats, etc.] and not a Psychiatrist, about it. Google account, for now, is no longer required to comment, but moderation is in effect.